Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN46216631
ISRCTN46216631
Completed
Not Applicable

The efficacy and safety of new moisturizing cream for dry skin condition and itch relief: a randomized, double-blind, placebo-controlled trial

Korea Health Industry Development Institute (KHIDI) (South Korea)0 sites66 target enrollmentJune 20, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDry skin condition in healthy volunteersSkin and Connective Tissue Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dry skin condition in healthy volunteers
Sponsor
Korea Health Industry Development Institute (KHIDI) (South Korea)
Enrollment
66
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 20, 2013
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Korea Health Industry Development Institute (KHIDI) (South Korea)

Eligibility Criteria

Inclusion Criteria

  • •1\. Volunteer individuals aged 20 to 65 years, either sex
  • •2\. Written and informed consent
  • •3\. Healthy volunteers without skin disease or any other diseases (acute or chronic)
  • •4\. Diagnosed with dry skin condition by the doctor (Korean Medicine), or presented with itching or dry skin condition
  • •5\. Available for follow\-up observations during clinical trial period

Exclusion Criteria

  • •1\. Pregnancy, lactating, or planned pregnancy
  • •2\. People who use external application containing steroids for the treatment of skin disease more than one month
  • •3\. Participated in the same trial within six months from the interview
  • •4\. People with hypersensitive skin
  • •5\. Skin abnormalities such as severe acne, erythema, telangiectasia on the test site
  • •6\. Used the same or similar cosmetic (or pharmaceutical) on the test site within three months from the interview
  • •7\. Have peeling of skin or wrinkles removed within six months from the interview
  • •8\. Other unsuitable reasons for clinical trial based on the discretion of the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Evaluating effectiveness of the moisturizing cream produced by Behpad Teb CompanySkin dryness.
IRCT20190210042676N28Iranian Behpad Teb Company20
Completed
Phase 3
MADEC Study
JPRN-jRCTs031190201Katsunuma Toshio86
Not yet recruiting
Not Applicable
Effective comparative study of moisture cream for itching in the senile dry skiasteatotic eczema
JPRN-UMIN000025770Department of Dermatology, Osaka University Graduate School of Medicine30
Completed
Phase 2
Clinical Efficacy and Safety of Innovated Cream from Thai Medicinal Plants (Garcinia/Arthrinox/Bim A) Versus Diclofenac Gel in Symptomatic Treatment of Osteoarthritis of KneeKnee osteoarthritisMild to moderate knee painKnee osteoarthritisTopical drugsThai medicinal plantsDiclofenac gel
TCTR20171123002Department of Pharmacology, Faculty of Medicine, Chiang Mai University200
Active, not recruiting
Phase 1
Assessment of the activity of a new cream containing betamethasone dipropionate at 0.010%, 0.025% and 0.050% versus reference products using a vasoconstriction assay in healthy subjects.Topical treatment of inflammatory dermatosis linked to cutaneous dryness
EUCTR2008-007173-20-FRPierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre40